Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
There is loss of expression of...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
There is loss of expression of S100A8 and S100A9 in oesophageal squamous carcinoma
Bibliographic Details
Main Authors:
Clarke, L
,
Rehman, I
,
Leiblich, A
,
Bury, J
,
Ackroyd, R
,
Stoddard, C
,
Wyman, A
,
Harrison, R
,
Hamdy, F
,
Cross, S
Format:
Conference item
Published:
2005
Holdings
Description
Similar Items
Staff View
Similar Items
Tissue microarray immunohistochemistry for S100A2, S100A4, S100A6, S100A8, S100A9, S100B and annexin I with unsupervised cluster analysis produces a useful classification of oesophageal cancers
by: Clarke, L, et al.
Published: (2005)
Expression of S100A2, S100A4, S100A6 and S100A7 in oesophageal cancers follows the pattern of expression in the tissues from which they are derived and does not show any significant association with any other clinicopathological parameters
by: Clarke, L, et al.
Published: (2005)
S100A9 protein is overexpressed in human breast and squamous cell cancers
by: Cross, S, et al.
Published: (2004)
Expression of beta-dystroglycan is lost in squamous cell and adenocarcinomas of the oesophagus and this loss is significantly related to increasing tumour stage
by: Parbery-Clark, C, et al.
Published: (2005)
S100A8 protein is expressed in neutrophils, macrophages, some breast cancers and some squamous cell cancers
by: Cross, S, et al.
Published: (2004)